ArticleERJ open research2026
Phase III AIRTIVITY study design: verducatib (BI 1291583) in people with bronchiectasis.
James D Chalmers et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleERJ open research2026
James D Chalmers et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.